Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,780 | -8,206 | 4,677 | -10,517 | -9,972 |
| Depreciation Amortization | 3,322 | 6,385 | 6,099 | 1,516 | 1,685 |
| Accounts payable and accrued liabilities | 2 | 27 | 874 | 12 | -210 |
| Other Working Capital | 348 | -86 | 800 | 305 | 540 |
| Other Operating Activity | 367 | 560 | -13,902 | 4,250 | 5,145 |
| Operating Cash Flow | $-740 | $-1,321 | $-1,453 | $-4,435 | $-2,812 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 656 | 1,410 | N/A | 943 | 345 |
| Debt Issued | N/A | N/A | 966 | 2,123 | N/A |
| Common Stock Issued | N/A | -125 | 159 | 1,965 | 2,929 |
| Other Financing Activity | 0 | -35 | 0 | -502 | -50 |
| Financing Cash Flow | $656 | $1,250 | $1,125 | $4,529 | $3,224 |
| Beginning Cash Position | 190 | 262 | 589 | 494 | 82 |
| End Cash Position | 106 | 190 | 262 | 589 | 494 |
| Net Cash Flow | $-84 | $-71 | $-327 | $95 | $412 |
| Free Cash Flow | |||||
| Operating Cash Flow | -740 | -1,321 | -1,453 | -4,435 | -2,812 |
| Free Cash Flow | -740 | -1,321 | -1,453 | -4,435 | -2,812 |